THE FANCONI-ANEMIA POLYPEPTIDE FACC IS LOCALIZED TO THE CYTOPLASM

被引:120
作者
YAMASHITA, T
BARBER, DL
ZHU, Y
WU, N
DANDREA, AD
机构
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV PEDIAT ONCOL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CELLULAR & MOLEC BIOL,BOSTON,MA 02115
关键词
MITOMYCIN C; LEUKEMIA SUSCEPTIBILITY;
D O I
10.1073/pnas.91.14.6712
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and chromosomal instability. A cDNA encoding the FA complementation group C (FACC) polypeptide was recently cloned [Strathdee, C. A., Gavish, H., Shannon, W. R. and Buchwald, M. (1992) Nature (London) 356, 763-767]. To further characterize this polypeptide, we generated a rabbit polyclonal antiserum against its carboxyl terminus. We used this antiserum to analyze the FACC polypeptide from normal or mutant (FA) lymphoblast cell lines. By immunoprecipitation, the wild-type FACC was a 60-kDa protein, consistent with its predicted molecular mass. FA group C cell lines expressed full-length FACC, truncated FACC, or no detectable FACC polypeptide. In addition, the antiserum specifically immuno precipitated a 50-kDa and a 150-kDa FACC-related protein (FRP-50 and FRP-150). Unexpectedly, cell fractionation and immunofluorescence studies demonstrated that the FACC polypeptide localizes to the cytoplasm. In conclusion, we have generated an antiserum specific for the human FACC polypeptide. The antiserum should be useful for screening FA cells for mutant FACC polypeptides and for identifying and cloning FACC-related proteins.
引用
收藏
页码:6712 / 6716
页数:5
相关论文
共 27 条
[11]  
GILLE JJP, 1987, HUM GENET, V77, P28
[12]  
HARLOW E, 1988, ANTIBODIES LAB MANUA, P92
[13]   IDENTIFICATION OF CELLULAR PROTEINS THAT CAN INTERACT SPECIFICALLY WITH THE T/E1A-BINDING REGION OF THE RETINOBLASTOMA GENE-PRODUCT [J].
KAELIN, WG ;
PALLAS, DC ;
DECAPRIO, JA ;
KAYE, FJ ;
LIVINGSTON, DM .
CELL, 1991, 64 (03) :521-532
[14]   DNA-REPAIR DEPENDENT NAD+ METABOLISM IS IMPAIRED IN CELLS FROM PATIENTS WITH FANCONIS ANEMIA [J].
KLOCKER, H ;
AUER, B ;
HIRSCHKAUFFMANN, M ;
ALTMANN, H ;
BURTSCHER, HJ ;
SCHWEIGER, M .
EMBO JOURNAL, 1983, 2 (03) :303-307
[15]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[16]   SPECIFIC INTERACTION BETWEEN THE P53 CELLULAR TUMOR-ANTIGEN AND MAJOR HEAT-SHOCK PROTEINS [J].
PINHASIKIMHI, O ;
MICHALOVITZ, D ;
BENZEEV, A ;
OREN, M .
NATURE, 1986, 320 (6058) :182-185
[17]  
PRITSOS CA, 1986, CANCER RES, V46, P3528
[18]   AN IMPROVED COLORIMETRIC ASSAY FOR CELL-PROLIFERATION AND VIABILITY UTILIZING THE TETRAZOLIUM SALT XTT [J].
ROEHM, NW ;
RODGERS, GH ;
HATFIELD, SM ;
GLASEBROOK, AL .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 142 (02) :257-265
[19]  
SASAKI MS, 1973, CANCER RES, V33, P1829
[20]  
SCHINDLER D, 1988, AM J HUM GENET, V43, P429